Fischer Medical Ventures Ltd. (FISCHER) is significantly underperforming compared to its peers across multiple metrics, indicating broad-based selling pressure in the Chemicals sector. It shows no revenue growth and high PE and PBV ratios, suggesting it is both overvalued and financially weak relative to more profitable competitors.

• • FISCHER shows 0% revenue growth YoY and 3-Year, indicating stagnation.
• • Highest PE ratio (10,332.68) indicates overvaluation versus peers.
• • Lowest ROE (4.60%) and ROA (4.24%) reveal poor profitability.
• • Best value pick is Pidilite Industries Ltd. due to strong growth and low PEG ratio.
• • Financially weak companies include Godrej Industries with high debt and low margins.